1. Patients with HS had higher risks of depression/anxiety.
2. Study involved 10,206 HS patients.
3. Mental health risk was consistent across disease severities.
4. Treatment types did not affect psychiatric risk.
5. Routine mental health screening is recommended.
6. Psychosocial burdens contribute significantly to psychiatric vulnerability.
7. Future studies needed to identify risk factors and interventions.

Source: JAMA Dermatology